ヒト成長ホルモンの市場規模、シェア、成長分析、製品別、用途別、流通チャネル別、地域別 - 産業予測、2024年～2031年

ヒト成長ホルモンの世界市場規模は、2022年に55億米ドルと評価され、2023年の63億2,000万米ドルから2031年には160億3,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは12.34％で成長する見通しです。

ヒト成長ホルモン（HGH）市場は、ターナー症候群、プラダー・ウィリー症候群、慢性腎臓病などの成長ホルモン欠乏症や関連疾患に対処することを目的としています。市場は、これらの疾患の有病率の増加や、HGH療法の利点に関する患者やヘルスケアプロバイダーの意識の高まりによって牽引されています。しかし、治療費の高騰、厳しい規制、処方箋に基づく投与の必要性といった課題が、市場の成長を妨げています。こうした課題にもかかわらず、HGH市場には、精密医療や個別化治療の開拓、再生医療、ホルモン補充療法、加齢関連疾患に関する進行中の研究、治療成果を高めるドラッグデリバリー技術の進歩など、機会があふれています。全体として、HGH市場は成長ホルモン関連疾患の管理において重要な役割を担っており、バイオテクノロジーの進歩と意識の高まりに支えられています。

目次

イントロダクション

• 調査の目的
• 定義
• 市場範囲

調査手法

• 情報調達
• 二次データソースと一次データソース
• 市場規模予測
• 市場の想定と制限

エグゼクティブサマリー

• 市場概要見通し
• 供給需要動向分析
• セグメント別機会分析

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主な市場の考察

• 主な成功要因
• 競合の程度
• 主な投資機会
• 市場のエコシステム
• 価格分析
• PESTEL分析

ヒト成長ホルモン市場：製品別

• 市場概要
• 長時間作用型
• その他

ヒト成長ホルモン市場：用途別

• 市場概要
• 成長ホルモン（GH）欠乏症
  • 成人成長ホルモン欠乏症
  • 小児成長ホルモン欠乏症
• ターナー症候群
• 特発性低身長
• プラダー・ウィリー症候群
• 低出生体重児
• その他

ヒト成長ホルモン市場：流通チャネル別

• 市場概要
• 病院薬局
• 小売薬局
• オンライン薬局
• 専門薬局

ヒト成長ホルモン市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• Novo Nordisk A/S
• Pfizer, Inc
• Eli Lilly and Company
• Sandoz International GmbH（Novartis AG）
• Merck KGaA
• Genentech, Inc（Roche）
• Ferring Pharmaceuticals
• Teva Pharmaceutical Industries, Ltd
• Ipsen
• GeneScience Pharmaceuticals
• LG Chem
• Anhui Anke Biotechnology Group
• Biopartners
• Endo International
• Versartis
• Opko Health
• Rani Therapeutics
• Somatopac
• Hua'an Biological
• Hangzhou Just Biotech
• Shenzhen Hybio Pharmaceutical

Global Human Growth Hormone Market size was valued at USD 5.5 billion in 2022 and is poised to grow from USD 6.32 billion in 2023 to USD 16.03 billion by 2031, growing at a CAGR of 12.34% during the forecast period (2024-2031).

The human growth hormone (HGH) market aims to address growth hormone deficiencies and related disorders, including conditions like Turner syndrome, Prader-Willi syndrome, and chronic kidney disease. The market is driven by the increasing prevalence of these disorders and growing awareness among patients and healthcare providers about the benefits of HGH therapy. However, challenges such as the high cost of therapy, stringent regulations, and the need for prescription-based administration hinder market growth. Despite these challenges, opportunities abound in the HGH market, including the development of precision medicine and personalized treatments, ongoing research into regenerative medicine, hormone replacement therapy, and age-related disorders, and advancements in drug delivery technologies that enhance treatment outcomes. Overall, the HGH market plays a crucial role in managing growth hormone-related disorders and is supported by advancements in biotechnology and increasing awareness.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Human Growth Hormone market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Human Growth Hormone Market Segmental Analysis

Global Human Growth Hormone Market is segmented by Product, Application, Distribution Channel and region. Based on Product, the market is segmented into Long Acting, Others. Based on Application, the market is segmented into Growth Hormone (GH) Deficiency (Adult GH Deficiency, Pediatric GH Deficiency), Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Small For Gestational Age, Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Specialty Pharmacy. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Drivers of the Global Human Growth Hormone Market

The rising prevalence of growth hormone-related disorders, including growth hormone deficiency and genetic conditions, is fueling the demand for HGH therapy. In 2022, heightened awareness and improved diagnostic capabilities led to more patients seeking treatment. According to the European Society for Paediatric Endocrinology (ESPE), there was a notable increase in the incidence of growth hormone deficiency among children in Europe during that year. This surge in cases has driven a greater need for HGH therapy to address growth hormone-related issues in affected children.

Restraints in the Global Human Growth Hormone Market

The high costs associated with HGH treatment can create significant barriers to access for some patients and healthcare systems. A 2022 study published in a medical journal underscored the financial strain that both patients and healthcare providers experience due to the steep price of HGH therapy. This highlighted the urgent need for more cost-effective solutions and potential pricing reforms to improve accessibility to HGH treatment.

Market Trends of the Global Human Growth Hormone Market

Physicians and researchers are increasingly prioritizing personalized HGH therapy, considering individual patient characteristics such as genetic factors and specific medical conditions. In 2022, a clinical trial was launched to assess the effectiveness of personalized dosing regimens for HGH therapy in children with growth hormone deficiency. The goal of this trial was to determine the advantages of tailored treatment approaches in enhancing growth outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Pricing Analysis
• PESTEL Analysis

Human Growth Hormone Market, By Product

• Market Overview
• Long Acting
• Others

Human Growth Hormone Market, By Application

• Market Overview
• Growth Hormone (GH) Deficiency
  • Adult GH Deficiency
  • Pediatric GH Deficiency
• Turner Syndrome
• Idiopathic Short Stature
• Prader-Willi Syndrome
• Small For Gestational Age
• Other

Human Growth Hormone Market, By Distribution Channel

• Market Overview
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Specialty Pharmacy

Human Growth Hormone Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Novo Nordisk A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer, Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sandoz International GmbH (Novartis AG)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genentech, Inc (Roche)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferring Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries, Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ipsen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneScience Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LG Chem
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anhui Anke Biotechnology Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biopartners
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endo International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Versartis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Opko Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rani Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Somatopac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hua'an Biological
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hangzhou Just Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Hybio Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments